MCh Pediatric Orthopedics: Admission, Medical School, Fees, Eligibility Criteria

Published Date: 06 Mar 2023

The Master Chirurgiae in Pediatric Orthopedics, also known as MCh Pediatric Orthopedics or MCh in Pediatric Orthopedics, is the highest degree...

Read Full News

Latest News

Enzyme provides promising path to degenerative joint diseases cure

Degenerative joint diseases like osteoarthritis and intervertebral disk degeneration are conditions that affect millions of people worldwide, leading to pain and reduced mobility. These diseases remain incurable because current ...

New points to consider in treatment-resistant psoriatic arthritis

Some people with psoriatic arthritis (PsA) may have a disease that is difficult to manage (D2M) or does not respond to treatment. EULAR—The European Alliance of Associations for Rheumatology—has released new evidence-based ...

Study finds improvement in knee pain with exercise and physical therapy

People with a meniscal tear and osteoarthritis prescribed home exercises with or without physical therapy reported substantial improvements in knee pain, according to a new study led by Mass General Brigham researchers.

New genetic marker could improve prediction of severe gout drug reactions in US patients

A newly identified genetic marker may significantly improve the ability to predict life-threatening reactions to the gout medication allopurinol in U.S. patients.

SGLT-2 inhibitors tied to lower risk for autoimmune rheumatic diseases in adults with type 2 diabetes

Sodium-glucose cotransporter-2 (SGLT-2) inhibitors are associated with a reduced risk for autoimmune rheumatic diseases compared with sulfonylureas among adults with type 2 diabetes, according to a study published online ...

Simple screening tool can help uncover underdiagnosed back condition, study finds

For millions of people living with back pain, the cause is often elusive. One underrecognized culprit is axial spondyloarthritis (axSpA)—a form of inflammatory arthritis that primarily affects the spine and sacroiliac joints ...

Todays Updates

Improving Diabetic Macular Edema Care in Native American Communities: Real-World Insights and Culturally Responsive Approaches

Improving Diabetic Macular Edema Care in Native American Communities: Real-World Insights and Culturally Responsive Approaches

Targeting the PI3K/AKT/PTEN Pathway to Optimize Treatment for HR+/HER2- Breast Cancer

Targeting the PI3K/AKT/PTEN Pathway to Optimize Treatment for HR+/HER2- Breast Cancer

Navigating Treatment-Associated Adverse Events and Patient-Centered Supportive Care in HR+/HER2- Breast Cancer

Navigating Treatment-Associated Adverse Events and Patient-Centered Supportive Care in HR+/HER2- Breast Cancer

Optimizing Safe Administration of Novel Infusion Therapies in HR+/HER2- Advanced Breast Cancer

Optimizing Safe Administration of Novel Infusion Therapies in HR+/HER2- Advanced Breast Cancer

Optimizing Treatment Sequencing in Endocrine-Refractory HR+/HER2- Breast Cancer

Optimizing Treatment Sequencing in Endocrine-Refractory HR+/HER2- Breast Cancer

Evaluating the Latest Evidence on Emerging Somatostatin Receptor Ligands for Acromegaly

Evaluating the Latest Evidence on Emerging Somatostatin Receptor Ligands for Acromegaly

Navigating Advances in Cystic Fibrosis Care

Navigating Advances in Cystic Fibrosis Care

Todays Updates

Improving Diabetic Macular Edema Care in Native American Communities: Real-World Insights and Culturally Responsive Approaches

Improving Diabetic Macular Edema Care in Native American Communities: Real-World Insights and Culturally Responsive Approaches

Targeting the PI3K/AKT/PTEN Pathway to Optimize Treatment for HR+/HER2- Breast Cancer

Targeting the PI3K/AKT/PTEN Pathway to Optimize Treatment for HR+/HER2- Breast Cancer

Navigating Treatment-Associated Adverse Events and Patient-Centered Supportive Care in HR+/HER2- Breast Cancer

Navigating Treatment-Associated Adverse Events and Patient-Centered Supportive Care in HR+/HER2- Breast Cancer

Optimizing Safe Administration of Novel Infusion Therapies in HR+/HER2- Advanced Breast Cancer

Optimizing Safe Administration of Novel Infusion Therapies in HR+/HER2- Advanced Breast Cancer

Optimizing Treatment Sequencing in Endocrine-Refractory HR+/HER2- Breast Cancer

Optimizing Treatment Sequencing in Endocrine-Refractory HR+/HER2- Breast Cancer

Evaluating the Latest Evidence on Emerging Somatostatin Receptor Ligands for Acromegaly

Evaluating the Latest Evidence on Emerging Somatostatin Receptor Ligands for Acromegaly

Navigating Advances in Cystic Fibrosis Care

Navigating Advances in Cystic Fibrosis Care

Latest News

Degenerative joint diseases like osteoarthritis and intervertebral disk degeneration are conditions that affect millions of people worldwide, leading to pain and reduced mobility. These diseases remain incurable because current ...

Some people with psoriatic arthritis (PsA) may have a disease that is difficult to manage (D2M) or does not respond to treatment. EULAR—The European Alliance of Associations for Rheumatology—has released new evidence-based ...

People with a meniscal tear and osteoarthritis prescribed home exercises with or without physical therapy reported substantial improvements in knee pain, according to a new study led by Mass General Brigham researchers.

A newly identified genetic marker may significantly improve the ability to predict life-threatening reactions to the gout medication allopurinol in U.S. patients.

Sodium-glucose cotransporter-2 (SGLT-2) inhibitors are associated with a reduced risk for autoimmune rheumatic diseases compared with sulfonylureas among adults with type 2 diabetes, according to a study published online ...

For millions of people living with back pain, the cause is often elusive. One underrecognized culprit is axial spondyloarthritis (axSpA)—a form of inflammatory arthritis that primarily affects the spine and sacroiliac joints ...

News All Time

Seven-year study reveals rheumatoid arthritis begins long before symptoms, opening door to prevention 

Scientists have discovered that rheumatoid arthritis (RA) doesn't start when the pain begins. It silently starts years earlier. RA is a debilitating autoimmune disease that causes painful joint inflammation and damage. The ...

Self-guided online program improves quality of life in rheumatoid arthritis, psoriatic arthritis and lupus

Patients with rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus frequently face anxiety and depression along with chronic physical symptoms. Reported rates of depression range from 15% to 24% and ...

Analysis isolates population aging as primary driver of musculoskeletal disorders

Novel research shows that in approximately one third of countries and territories worldwide, population aging was the largest contributor to the growing burden of musculoskeletal disorders from 1990 to 2021.

Tirzepatide found to be more cost-effective than semaglutide in patients with knee osteoarthritis, obesity

A microsimulation model was used to evaluate the cost-effectiveness of two glucagon-like peptide-1 receptor agonists (GLP1RAs), semaglutide and tirzepatide, for patients with osteoarthritis and obesity compared with usual ...

Current research may open doors to new treatments for children with juvenile dermatomyositis

Children with a rare, debilitating muscle disease could benefit from the findings of new research by experts at UCL and Great Ormond Street Hospital (GOSH).

Squishy 'smart cartilage' could target arthritis pain as soon as flareups begin

Researchers have developed a material that can sense tiny changes within the body, such as during an arthritis flareup, and release drugs exactly where and when they are needed.

Immune aging may be a driver of rheumatoid arthritis rather than a consequence

Features of immune system aging can be detected in the earliest stages of rheumatoid arthritis (RA), even before clinical diagnosis, a new study has found which provides at-risk individuals with hope for early intervention.

Common arthritis drug found to lower blood pressure and risk of heart disease

Methotrexate, a common medication used to treat rheumatoid arthritis, has a newly recognized useful secondary effect of lowering blood pressure and potentially reduces the risk of heart disease in people with this condition.

Noisy knees not an early arthritis sign, says new study

Knee crepitus, the sound of cracking or grinding in the knee joint, is very common across all age groups.

Q&A: These genetic insights into rheumatoid arthritis could help design better treatments

People with rheumatoid arthritis (RA) often have trouble getting out of bed in the morning, let alone getting to the rheumatologist for a checkup or participating in a research study. This makes a deeper understanding of ...

Benefits of long-term routine lab drug toxicity monitoring unclear in rheumatoid arthritis

For patients with rheumatoid arthritis (RA) using disease-modifying antirheumatic drugs (DMARDs), long-term routine laboratory toxicity monitoring (lt-RLTM) indicates that most very abnormal laboratory results are already ...

Back pain a $638 billion productivity black hole, Australian study warns

A new study from Monash University has revealed that long-term back problems will cost the Australian economy an estimated $638 billion in lost productivity over the next decade unless urgent action is taken.

Survey reveals people are not aware knee and groin pain can be signs of hip problems

Having a hard time bending over to put your shoes on? Experiencing pain in the knees, groin, thigh or back? A survey by The Ohio State University Wexner Medical Center reveals many people don't realize these symptoms can ...

Improving prediction of worsening knee osteoarthritis with an AI-assisted model

An artificial intelligence (AI)-assisted model that combines a patient's MRI, biochemical, and clinical information shows preliminary promise in improving predictions of whether their knee osteoarthritis may soon worsen. ...

Scientist uncover hidden immune 'hubs' that drive joint damage in rheumatoid arthritis

Rheumatoid arthritis (RA) is an autoimmune disease that affects millions worldwide and can have a devastating impact on patients' lives. Yet, about one in three patients respond poorly to existing treatments.

Lupus low disease activity state attainable in lupus nephritis

In lupus nephritis, attainment of complete renal response (CRR)/partial renal response (PRR) and lupus low disease activity state (LLDAS) is associated with best relapse-free survival, with independent associations seen with ...

Recommended News For You

Gene Therapy for Rare Brain Disease Effective, but Comes With Blood Cancer Risk

Alkem introduces cetuximab under the trade name Cetuxa in India.

The most precise research tools for the deadliest blood cancer have been developed.

Clinical trial: Patients with locally advanced, muscle-invasive bladder cancer do not benefit from extended lymph node removal.

Even when they are not paying attention, children are still learning.

June 20, 2023, Health Bulletin No. 12.

African American men see biggest survival gain from healthier lifestyles post prostate cancer diagnosis

Recommended Articles For You

ctDNA in Aggressive B-Cell Lymphoma: Redefining MRD and Prognostic Monitoring 

Beyond the Biopsy: The Evolving Landscape of Prostate Cancer Management 

Anemia in Older Adults: Causes, Clinical Impact, and Evidence-Based Management 

Bridging the Gap Between Cancer Treatment-Induced Cardiotoxicity and Regenerative Medicine 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

What is Mohs micrographic surgery? 8 FAQs about Mohs

2.

Trump slashed US cancer research by 31 percent: Senate report

3.

NEJM: Fluorescent guide can aid in the detection of tumors that are still present after breast cancer surgery.

4.

Children with the "Failure to Launch" Syndrome in Adulthood Have New Hope.

5.

Fear of hair loss might cause some to reject cancer treatment

1.

A New Dawn for Triple-Negative Breast Cancer: Emerging Therapies and the Art of Healing

2.

A New Hope: Exploring the Potential of Pegaspargase in Treating Cancer

3.

Unraveling the Genetic Mystery of Hereditary Spherocytosis

4.

Obesity as a major risk factor for cancer

5.

Unlocking the Potential of Cancer Antigen 19-9 for Early Detection

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I

2.

CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World

3.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV

4.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks

5.

"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot